There are 413 resources available
134P - Impact of pre-operative MammaPrint/BluePrint use for final treatment decisions in patients with Stage II/IIIa HR+/HER2- early-stage breast cancer eligible for neoadjuvant chemotherapy: the DETERMIND study.
Presenter: Sara Liebana
Session: Poster viewing and lunch
135P - Five-year survival analysis of phase II ZoNAnTax trial: Evaluation of Zoledronic-acid addition to a neoadjuvant Trastuzumab, Anthracycline and Docetaxel-containing regiment.
Presenter: Susanne Costa
Session: Poster viewing and lunch
136P - Clinical Implications of Non-Breast Cancer Related Findings in Breast Cancer Patients Undergoing PET/CT scan prior to Neoadjuvant Systemic Therapy
Presenter: Josefien van Olmen
Session: Poster viewing and lunch
137P - The Evaluation of the Effect of Inflammatory-Nutritional Prognostic Scoring (INPS) System on Treatment Response and Prognosis in Patients with Locally Advanced Breast Cancer Treated with Neoadjuvant Systemic Treatment
Presenter: Merve Keskinkilic
Session: Poster viewing and lunch
138P - Activity and Efficacy of Neoadjuvant Chemotherapy (NACT) in Luminal-HER2 Negative Early Breast Cancer (EBC) according to HER2 Score (Low vs Score 0): A Retrospective Study.
Presenter: Giovanna Garufi
Session: Poster viewing and lunch
139P - Assessing the predictive value of Systemic Inflammation Response Index (SIRI) and Systemic Immune-Inflammation Index (SII) for breast cancer patients undergoing neoadjuvant chemotherapy
Presenter: Maryam Bagherian
Session: Poster viewing and lunch
140P - HER2-low status and response to neoadjuvant chemotherapy and prognosis in early breast cancer
Presenter: Tae-Kyung Yoo
Session: Poster viewing and lunch
141P - Concurrent neoadjuvant endocrine therapy with chemotherapy in HR+HER2- breast cancer: a systematic review and meta-analysis
Presenter: Lv Wenjie
Session: Poster viewing and lunch
142P - The predictive value of progesterone receptor expression on pCR following neoadjuvant chemotherapy in breast cancer
Presenter: Henry Cain
Session: Poster viewing and lunch
143P - A single institution’s real-world experience with the neoadjuvant Keynote-522 treatment regimen
Presenter: Rachel Akers
Session: Poster viewing and lunch